Production

Comed was in 1986, when a team of experienced and energetic Pharma professionals decided to go big and to do something different and better than routine. A seed was sown: a beginning was made. These young, dynamic and experienced future leaders chose Baroda (Now called Vadodara), the Educational and Pharma capital of Gujarat (Western India) as their base, a choice which itself proved to be big contributing factor for growth.

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country.
Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

Genpharma Int. is an integrated pharma company having strong business across the globe including pan India domestic business with modern and state-of-art manufacturing plant certified by WHO-GMP norm & ISO 9001:2008 standard.

Hygienic Research Institute (HRI) has come a long way since 1957, with an aim to satisfy the consumer’s needs in the modern world.
HRI wanted people to look and feel beautiful, naturally. Hence, every beauty product of HRI has been prepared with the help of modern technology and ancient Ayurvedic sciences, giving the consumer the very best, to be the very best.

Sidmak focuses towards enhanced safety and comfort for the human lives through committed perfection and to service the domestic as well as global customers with the products of international standards.
Sidmak aims to become leading player in Novel Drug Delivery System and stretch its core competency to achieve a competitive and sustainable advantage in the global pharmaceutical industry.

Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) with eight molecules in various stages of clinical development. The company has a significant presence in branded generics markets across emerging economies including India. Its subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries.

Arch Pharmalabs has gained recognition as a world-class provider of small molecule process chemistry, custom synthesis services and full life-cycle API and drug intermediates manufacture for the global pharmaceutical industry. Generating revenues of USD 200 million, our India-based offering is supported by 2,400 customer-centric Archers, eleven certified facilities (including cGMP-compliant, US FDA- and EDQM-approved sites) and two state-of-the-art Process Technology centres.